Back
ESC Premium Access

Long term cardiovascular risk prediction in Real-World atrial fibrillation patients: Validation of the 2MACE score in the FANTASIIA registry.

Session: Poster Session 7 - Secondary prevention
Topic: Scores
Speaker: Doctor M. Esteve Pastor (Murcia, ES)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Maria Asuncion Esteve Pastor

Virgen de la Arrixaca University Clinical Hospital, Murcia (Spain)
0 follower

32 more presentations in this session

Impact of comorbidities on major adverse events in atrial fibrillation: 3 years follow-up of the EORP-AF general pilot registry

Speaker: Associate Professor M. Proietti (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

ABC-death risk score predicts mortality better than CHA2DS2-VASc score in a contemporary population of hospitalised patients with atrial fibrillation

Speaker: Professor G. Giannakoulas (Thessaloniki, GR)

Access
Abstract
Slides
Like
Thumbnail

Intima-Media thickness to better risk-stratify patients with premature coronary artery disease: an analysis from the AFUI registry.

Speaker: Doctor M. Zeitouni (Paris, FR)

Access
Abstract
Slides
Like
Thumbnail

Prognostic value of elevated electromagnetic QRS-fragmentation index on 5-year outcome in patients with acute myocardial infarction undergoing cardiac magnet field imaging

Speaker: Mr O. Mohammad (Ludwigshafen, DE)

Access
Abstract
Like
Thumbnail

The prognostic importance of pulmonary pressure increase in early cardiovascular diseases

Speaker: Doctor P. Giovanardi (Modena, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Poster Session 7 - Secondary prevention

Speakers: Doctor M. Esteve Pastor, Associate Professor M. Proietti, Professor G. Giannakoulas, Doctor M. Zeitouni, Mr O. Mohammad...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources